Heart failureNatriuretic peptide receptorsNesiritideThe B-type natriuretic peptide (BNP), a member of the family of vasoactive peptides, has emerged as an important diagnostic, prognostic, and therapeutic tool in patients with heart failure (HF). The rapid incorporation into clinical practice of ...
①BNP是心力衰竭(Heart Failure,HF)的定量标志物; ②BNP对于诊断HF高度准确; ③BNP可以帮助医生对急诊患者进行危险分层,以便判断是否入院; ④BNP有助于改善心衰患者的疾病管理,减少总治疗费用; ⑤BNP监测会节省6个月内费用; ⑥BNP是目前预测HF最可靠的生物标志物; ⑦BNP水平有助于评估出院的安全性; ⑧在BNP监测...
Heart failure is when your heart can't pump enough blood to provide your body with the blood and oxygen it needs. If you have this condition, it doesn't mean your heart stops working. It means your heart doesn't work as efficiently as usual. Blood moves through your heart and body at...
心力衰竭(heart failure) 是各种心脏疾病导致心功能不全(cardiac insufficiency)的一种综合征,绝大多数情况下是指心肌收缩力下降使心排血量不能满足机体代谢的需要,器官、组织血液灌注不足,同时出现肺循环和(或)体循环淤血的表现。少数情况下心肌收缩力尚可使心排血量维持正常,但由于异常增高的左心室充盈压,使肺静脉...
The assessment of BNP may predict the occurrence of stroke in CHF patients used alone or in combination with established CHADS2 score. 单独BNP或联合CHADS₂评分评估可预测CHF患者卒中的发生。 Introduction Currently, the mor...
His束起搏并没有增加峰值运动耗氧量(+0.25 ml/kg/min,P=0.3),但MLHFQ评分显著改善(-3.7,P=0.03),尽管EQ-5D VAS没有显著改善(+1.9,P=0.28)。His束起搏对LV大小、LVEF、血浆BNP和室性心律失常的发生率没有显著影响。 4. ...
Measurement of circulating natriuretic peptides has found a secure place in the diagnosis and management of patients with heart failure. In this issue of Heart, Khan and colleagues report that plasma levels of immunoreactive N-terminal pro-B-type natriuretic peptide (NTproBNP) provide prognostic info...
Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease... Background Cardiac natriuretic peptides are activated in heart failure. However, their diagnostic and prognostic values have not been compared under...
3.Advances in Heart Failure and Angina Diagnostics Diagnostic advancements in heart failure and angina have revolutionized the way these conditions are identified and managed. The use of biomarkers such as B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) has become integral in...
Given the high cost of inpatient heart failure (HF) treatment, HF places a major burden on the public health system and has an associated economic impact. Furthermore, repeating HF readmission could worsen the activity o...